NCT00651859

Safety and Efficacy Study of Bimatoprost in Ethnically Japanese Patients With Open-Angle Glaucoma or Ocular Hypertension

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 111 (actual)
• Sponsor: Allergan · Industry
• Sex: All
• Age: 20 Years
• Healthy volunteers: Not accepted

Summary

This study evaluates the safety and efficacy of once-daily bimatoprost 0.03% and 0.01% ophthalmic solutions compared with once-daily administered bimatoprost vehicle ophthalmic solution for 2 weeks in ethnically Japanese patients with open-angle glaucoma or ocular hypertension

Conditions

• Glaucoma
• Ocular Hypertension

Interventions

Type	Name	Description
DRUG	Bimatoprost 0.01% Ophthalmic Solution	Bimatoprost 0.01% ophthalmic solution 1 drop instilled in each eye once daily in the evening between 19:00 and 21:00
DRUG	Bimatoprost 0.03% Ophthalmic Solution	Bimatoprost 0.03% ophthalmic solution 1 drop instilled in each eye once daily in the evening between 19:00 and 21:00
DRUG	Bimatoprost Vehicle Ophthalmic Solution	Bimatoprost vehicle ophthalmic solution 1 drop instilled in each eye once daily in the evening between 19:00 and 21:00

Timeline

• Start date: 2002-11-01
• Primary completion: 2004-01-01
• Completion: 2004-01-01
• First posted: 2008-04-03
• Last updated: 2008-04-03

Locations

1 site across 1 country: United States